ENTITY

Access Bio Inc (950130 KS)

Analysis

Health Care • South Korea

Access Bio Inc. develops, manufactures, and markets in-vitro diagnostic (IVD) tests. The Company develops rapid diagnostic test (RDT) for Malaria and Pregnancy.

Refresh

No filings found

We’ll display filings we find for Access Bio Inc here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00